Nakamura Hiroshi, Umemoto Seiji, Naik George, Moe Gordon, Takata Satoko, Liu Peter, Matsuzaki Masunori
Department of Cardiovascular Medicine, Yamaguchi University School of Medicine, 1-1-1 Minami-koguchi, Ube, Yamaguchi 755-8505, Japan.
J Am Coll Cardiol. 2003 Jul 2;42(1):173-81. doi: 10.1016/s0735-1097(03)00504-7.
The present study investigated the effects of tumor necrosis factor (TNF)-alpha and angiotensin II (ANG II) on cardiac remodeling and dysfunction at the early stage of acute myocardial infarction (MI) by using a novel heterotopic cardiac transplantation-coronary ligation model.
A recent clinical study has demonstrated a possible role of monocytosis in the development of left ventricular (LV) remodeling in patients with acute MI reperfusion.
We performed isogenic heterotopic cardiac transplantation and simultaneous coronary ligation to produce MI in the donor heart and to evaluate the hearts of both donors and recipients in Lewis rats.
A significant decrease in LV fractional shortening and positive rate of rise in LV pressure and a significant increase in LV end-diastolic dimension/body weight and LV end-diastolic pressure were observed in the recipient hearts in the ligation group on day 7. TNF-alpha was significantly elevated not only in the plasma but also in the recipient hearts in the ligation group. In contrast, ANG II was significantly increased only in the infarct region of the donor hearts, but not in the plasma. Furthermore, the recipients' transient LV remodeling and dysfunction were completely abolished by the intravenous administration of a TNF-alpha antagonist. CONCLUSIONS; We developed a novel cardiac transplantation-coronary ligation model capable of inducing MI in the absence of downstream hemodynamic effects and allowing differential quantification of indexes of cardiac remodeling in vivo, including the local and remote effects of ANG II and TNF-alpha on cardiac remodeling.
本研究通过使用一种新型的异位心脏移植-冠状动脉结扎模型,探讨肿瘤坏死因子(TNF)-α和血管紧张素II(ANG II)在急性心肌梗死(MI)早期对心脏重塑和功能障碍的影响。
最近一项临床研究表明,单核细胞增多症在急性MI再灌注患者左心室(LV)重塑的发生中可能起作用。
我们进行了同基因异位心脏移植并同时进行冠状动脉结扎,以在供体心脏中产生MI,并评估Lewis大鼠供体和受体的心脏。
结扎组受体心脏在第7天时,左心室短轴缩短率显著降低,左心室压力上升阳性率显著降低,左心室舒张末期内径/体重和左心室舒张末期压力显著增加。TNF-α不仅在血浆中显著升高,在结扎组受体心脏中也显著升高。相比之下,ANG II仅在供体心脏梗死区域显著增加,而在血浆中未增加。此外,静脉注射TNF-α拮抗剂可完全消除受体的短暂左心室重塑和功能障碍。结论:我们开发了一种新型的心脏移植-冠状动脉结扎模型,该模型能够在没有下游血流动力学影响的情况下诱导MI,并允许在体内对心脏重塑指标进行差异量化,包括ANG II和TNF-α对心脏重塑的局部和远程影响。